drugset / Trial / NCT02361736
Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery
Completed
120 enrolled
Yuanyuan Zhang
Tianjin First Central Hospital · collabTianjin Union Medical Center · collab
RandomizedParallel-groupTriple-blind
Summary
Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old patients with normal renal function during orthopaedic surgery.
Timeline
- Start
- 2015-03
- Primary completion
- 2015-12
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lactate Ringers | Unknown | 7.5 unknown | Intravenous |
| Subject | hydroxyethyl starch | Other / unclassified | 7.5 unknown | Intravenous |
Indications
No indication recorded.